Daftary A, Adler RS
Impact of insulin degludec/liraglutide fixed combination on the gut microbiomes of elderly patients with type 2 diabetes: results from a subanalysis of a small non-randomised single arm study
Clemente-Postigo M, Munoz-Garach A, Serrano M, et al
Taken together, according to earlier research, SIRT1 can shorten the lifetime of cells through deacetylating the P53 protein, along with decreasing its transcriptional activity 126
The most robust clinical evidence arguably originates from the large cardiovascular outcomes trials (CVOTs) completed for most GLP-1 RAs, of which the latest showed a significant relative risk reduction (RRR) of 39% (HR) with once-weekly efpeglenatide on HF requiring hospitalisation, corroborating a meta-analysis which found a significant RRR across eight GLP-1 RA CVOTs of 11%
With our integrated platform covering Antibody Development, Protein Production, Gene Synthesis, Vector Construction, Protein Expression, and Purification, we provide one-stop services to fully meet your research needs.